Journal Article DKFZ-2021-01639

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition.

 ;  ;  ;  ;  ;  ;  ;  ;

2021
BioMed Central London

Journal for ImmunoTherapy of Cancer 9(7), e002319 () [10.1136/jitc-2020-002319]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: M2 macrophages promote tumor progression and therapy resistance, whereas proimmunogenic M1 macrophages can contribute to the efficacy of cytostatic and immunotherapeutic strategies. The abundance of M2 macrophages in the immune infiltrate of many cancer types has prompted the search for strategies to target and eliminate this subset. From our prior experiments in syngeneic mouse tumor models, we learned that pharmacological inhibition of mitogen-activated protein kinase kinase (MEK) did not merely result in tumor cell death, but also in the modulation of the tumor immune infiltrate. This included a prominent decrease in the numbers of macrophages as well as an increase in the M1/M2 macrophage ratio. Investigation of the mechanism underlying this finding in primary murine macrophage cultures revealed that M2 macrophages are significantly more sensitive to MEK inhibition-induced cell death than their M1 counterparts. Further analyses showed that the p38 MAPK pathway, which is activated in M1 macrophages only, renders these cells resistant to death by MEK inhibition. In conclusion, the dependency of M2 macrophages on the MEK/extracellular-signal regulated kinase (ERK) pathway empowers MEK inhibitors to selectively eliminate this subset from the tumor microenvironment.

Keyword(s): drug evaluation ; immunomodulation ; macrophages ; preclinical ; tumor microenvironment

Classification:

Note: #EA:D200#LA:D200#

Contributing Institute(s):
  1. Molekulare Grundlagen Gastrointestinaler Tumoren (D200)
Research Program(s):
  1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2021
Database coverage:
Medline ; Creative Commons Attribution-NonCommercial CC BY-NC (No Version) ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2021-07-23, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)